explore -WSS

explore

author：explore 2025-09-30 14:10:12 - browse：31534

Why are addiction treatments so hard to get? Can small companies compete in obesity? And since when is “Series E” a thing in biotech?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. For the entirety of the opioid overdose epidemic, the U.S. has had readily available tools that are proven to save lives. STAT’s Lev Facher joins us to explain his reporting on why virtually every sector of American society is standing in the way of their use. We also discuss the latest news in the life sciences, including the haves and have-nots of venture capital, and the race to develop effective oral treatments for obesity.

For more on what we cover, here’s the story on addiction medicine; here’s the latest on biotech financing; here’s more on Novo Nordisk’s oral obesity treatment; here’s where you can find episodes of Color Code; here’s where you can subscribe to the First Opinion Podcast; and here’s where you can subscribe to our biotech newsletter, The Readout.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

Previous article： Drug repurposing or repositioning? The language matters
Next article： It was time to plan for my old age. If only I could stop crying

focus

WSS

BridgeBio heart drug succeeds in pivotal study

Sage considers ways to reduce costs following FDA rejection

Google's generative AI to analyze medical images — and talk to docs

Flash flood warnings continue for parts of Missouri, Illinois

Sage considers ways to reduce costs following FDA rejection

Election results set back Medicaid expansion plans

focus

explore

hotspot

Moonlake's readout produced a cash windfall. Risks remain

Vivek Ramaswamy, who's embraced Trump on the campaign trail, condemned him after Jan. 6

In age of alternative facts, a scholarly course on calling out crap

Vivek Ramaswamy, who's embraced Trump on the campaign trail, condemned him after Jan. 6

Medical leaders decry Supreme Court decision on affirmative action

Severe weather updates: 1 million customers without power in 11 states as storms pummel East Coast

Wildfire smoke exposes gaps in outdoor worker protections

Twill hunts for pharma partner to market its depression app

Apple is now the first public company to be valued at $3 trillion

Russia promises retaliation after Ukrainian drones hit a Russian tanker in 2nd sea attack in a day

focus

Russia promises retaliation after Ukrainian drones hit a Russian tanker in 2nd sea attack in a day

FDA seeking to stop procedures at two unregulated stem cell clinics

Many breast cancer patients receive more radiation than needed

Feed a cold, starve a fever? Here’s what science says

Democrats are overperforming in 2023's special elections. Is it a clue for Biden vs. Trump?

US soldier in North Korean custody after crossing DMZ line

focus

focus

focus

leisure time